Be a Smart Investor
Monday, March 4, 2019
Biogen to buy Nightstar Therapeutics in a $800 million cash deal
Biogen said on Monday it will buy Nightstar Therapeutics for about $800 million in cash as the company looks to tap into a potentially lucrative gene therapy market.
from Deals and IPOs https://ift.tt/2NH36HJ
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment